Company: BLRX
Filing Date: 2025-01-07
Form Type: 424B5
Source: 0001178913-25-000045
Chunk: 66

Company: BioLineRx Ltd.
Filing Date: 2025-01-07
Form: 424B5
Chunk 66
---
 issuing additional securities of the same series in lieu of cash (and the terms upon which any such interest may be paid by issuing additional securities); |

| • | the terms for redemption, extension, or early repayment, if any; |

| • | the currencies in which the series of debt securities are issued and payable; |

| • | whether the amount of any payments of principal, premium or interest, if any, on a series of debt securities will be determined with reference to an index, formula or other method (which could be based on 
 one or more currencies, commodities, equity indices or other indices) and how these amounts will be determined;                                                                                              |

| • | the place or places, if any, other than or in addition to the Borough of Manhattan in the City of New York, of payment, transfer, conversion and/or exchange of the debt securities; |

| • | the denominations in which the offered debt securities will be issued (if other than $1,000 and any integral multiple thereof for registered securities); |

| • | the provision for any sinking fund; |

18

| • | any restrictive covenants; |

| • | any Events of Default (as defined below); |

| • | whether the series of debt securities are issuable in certificated form; |

| • | any provisions for defeasance or covenant defeasance; |

| • | any provisions regarding any future changes or modifications of the terms of the series of debt securities in light of the requirements under applicable law for effecting such changes or modifications; |

| • | any special Israeli and/or U.S. federal income tax implications, including, if applicable, Israeli and/or U.S. federal income tax considerations relating to original issue discount; |

| • | whether and under what circumstances we will pay additional amounts in respect of any tax, assessment, or governmental charge and, if so, whether we will have the option to redeem the debt securities rather 
 than pay the additional amounts (and the terms of this option);                                                                                                                                                |

| • | any provisions for convertibility or exchangeability of the debt securities into or for any other securities; |

| • | whether the debt securities are subject to subordination and the terms of such subordination; |

| • | whether the debt securities are secured or unsecured and the terms of any security interests; |

| • | the listing, if any, on a securities exchange; and |

| • | any other terms. |

General The indenture provides that any debt securities